Navigation Links
Rempex Announces Series B Financing of Up to $67.5 Million
Date:11/9/2011

SAN DIEGO, Nov. 9, 2011 /PRNewswire/ -- Rempex Pharmaceuticals, Inc. today announced that it has completed the initial closing of a Series B financing.  New investors Frazier Healthcare Ventures and Vivo Ventures joined existing investors SV Life Sciences, OrbiMed Advisors and Adams Street Partners in committing to a total of $67.5 million for this round.  This financing, together with a previous Series A round, brings the total financing commitment for Rempex to $76 million since the company's founding in June 2011.

Rempex is focused on developing internally discovered new treatments for resistant gram-negative infections.  The company expects to file a New Drug Application (NDA) with the United States Food and Drug Administration (FDA) for its first product candidate in the second half of 2012 and an Investigational New Drug Application (IND) with the FDA for its second product candidate in the first quarter of 2012.

"We are very pleased to have been able to attract such a strong group of experienced healthcare investors," stated Daniel Burgess, President and Chief Executive Officer of Rempex.  "This financing gives us the resources to rapidly advance our development programs towards commercialization at a time when the need for new treatments for resistant gram-negative infections has become critical."

About Rempex Pharmaceuticals

Rempex Pharmaceuticals, Inc. is a biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. The company was founded to acquire all the assets, including financial and human resources, not associated with Aeroquin™ from Mpex Pharmaceuticals, Inc.  Aptalis Holdings Inc. acquired Mpex and its lead product candidate, Aeroquin™, earlier this year.  Company website: www.rempexpharma.com


'/>"/>
SOURCE Rempex Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Amylin Pharmaceuticals Announces Date and Time Change to Previously Announced Presentation at the Credit Suisse 2011 Healthcare Conference
2. NeuroDerm Announces Positive Results of a Phase II Study of ND0611 Dermal Patch in Patients with Parkinsons Disease
3. China Sky One Medical Announces Third Quarter 2011 Results
4. China Information Technology, Inc. Announces Third Quarter 2011 Results
5. Uroplasty Announces Issuance of New Apparatus Patent for the Urgent® PC Neuromodulation System Stimulator
6. Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System
7. K-V Pharmaceutical Announces Updated Makena® Performance Metrics
8. MedBox Announces Ticker Symbol Change
9. SMT Research & Development, Ltd. Names Shuki Porath as Vice President and General Manager, Announces TCT Presence
10. ECRI Institute Announces its Top 10 Health Technology Hazards for 2012
11. Echo Therapeutics Announces Third Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 OpportunityAnalyzer: Cushing,s Syndrome - Opportunity ... GlobalData estimates that the 2013 sales for the ... across the 6MM covered in this report. Pharmaceutical ... time, and financial resources in the CS field, ... (R&D) strategies. One notable example is the fact ...
(Date:5/27/2015)... May 27, 2015 ... has announced the addition of the  "2015 ... Market"  report to their offering. ... issues pertaining to the US NAT laboratory ... demographic, social and technological trends with significant ...
(Date:5/27/2015)... Research and Markets ( ... the  "US Cancer Vaccine Market Outlook 2020" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,Cancer vaccines ... categories of prophylactic (preventive) and therapeutic (treatment) ... both of these groups have been marketed ...
Breaking Medicine Technology:OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 3OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 4United States Nucleic Acid Testing Market Strategies 2015-2020 2US Cancer Vaccine Market Outlook 2020 2US Cancer Vaccine Market Outlook 2020 3
... - Termination of Parkinson,s Disease Clinical Development and Focus ... Neuropathic Pain and Epilepsy ... is a first-in-class,orally administered, highly selective non-competitive AMPA-type glutamate,receptor ... disease, neuropathic pain, epilepsy, multiple,sclerosis and migraine prophylaxis., ...
... Napo,Pharmaceuticals, Inc., (LSE: NAPL and NAPU) is pleased ... Phase 2 trial for CRO-ID,(crofelemer for the treatment ... Glenmark Pharmaceuticals Limited (BSE: Glenmark). The,primary endpoints of ... frequency and stool consistency; additional endpoints followed,include degree ...
Cached Medicine Technology:Status of the E2007 (perampanel) Development Program 2Status of the E2007 (perampanel) Development Program 3Status of the E2007 (perampanel) Development Program 4Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 2Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 3Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 4Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 5
(Date:5/28/2015)... 2015 First Choice Emergency Room ... in the United States, announced that it is expanding ... Green Valley Ranch facility. , “I am pleased ... the highest quality emergency medical care to Denver residents ... said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:5/28/2015)... CA (PRWEB) May 28, 2015 Although ... they are stuck with their slow metabolism for life, ... weight, this is not true. There are methods to ... increase their advertisements for low-carbohydrate, low-fat and no-fat foods, ... are eating healthy, many times the foods contain hidden ...
(Date:5/28/2015)... Orem, UT—Dymicron, Inc., (dymicron.com) confirmed the ... unique Triadyme-C cervical total disc replacement device. The two ... Smith at the American Institute of Minimally Invasive Surgery ... well to the implantation of the Dymicron devices,” said ... and Chief of Neurosurgery for the University Medical Center, ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Dallas ... updated version of his patient education website ... redesign allows patients to readily access current educational ... dysfunction treatment, male urinary incontinence, prostate cancer treatment, ... of this website is to educate patients on ...
(Date:5/28/2015)... Provo, Utah (PRWEB) May 28, 2015 ... corporate training, is pleased to announce that Career Step ... speaker in a June 4 webinar presented by ICD10monitor ... Clinical Documentation at HRS. Mr. Hodgson and Ms. Carr ... training for a successful ICD-10 transition. , “We have ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room to Open New Facility in Denver, Colorado 2Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 2Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 3Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 4Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2Health News:Mark Allen MD, Dallas Urologist, Launches Updated Patient Education Website With a Focus on Prostate Cancer and Erectile Dysfunction Treatment 2Health News:Career Step and HRS Hosting June 4 ICD10monitor Webinar on the Importance of Auditing and Physician Training for ICD-10 Success 2Health News:Career Step and HRS Hosting June 4 ICD10monitor Webinar on the Importance of Auditing and Physician Training for ICD-10 Success 3
... Autism Association Push,for Services Worldwide, BETHESDA, Md., ... April 2 as World Autism Awareness Day. To ... the World Autism,Organization and the Co-Chairs of the ... Rep. Chris Smith and Rep.,Mike Doyle, will hold ...
... pharmaceutical industry currently underway will increase in the next ... at the National Institutes of Health (NIH) who is ... , According to Christopher Austin, M.D., director ... and academia welcome more cooperation in drug discovery to ...
... CHICAGO, Ill. (April 1, 2008) A new bioabsorbable ... threading catheters into the body during diagnostic angiography and ... to get up and walk around far sooner than ... addition, there were no access site complications at 30 ...
... Include Economic Development Stimulus ... as Means to Address Social Issues, DETROIT, ... today announced a total of $50,000 in grants to,the Detroit ... for innovative community programs,demonstrating a broader scope for the charitable ...
... Top Five Global Market ... ... (UL), a world leader of product safety testing services,announced today that ... registrar in independent third party management,system certification services headquartered in Frankfurt ...
... ... With U.S. Presence, AMSTERDAM, The Netherlands, ... evolving field of cancer molecular diagnostics,today announced the appointment of Richard ... medical officer (CMO). Dr. Bender, who,will report directly to Chief Executive ...
Cached Medicine News:Health News:Reps. Smith and Doyle, Autism Society of America Push Landmark Legislation on World Autism Awareness Day 2Health News:Reps. Smith and Doyle, Autism Society of America Push Landmark Legislation on World Autism Awareness Day 3Health News:Business of drug development on verge of great change 2Health News:ExoSeal vascular plug gets good reviews in ECLIPSE study 2Health News:Ilitch Charities Invests $50,000 in Innovative Community Programs 2Health News:Ilitch Charities Invests $50,000 in Innovative Community Programs 3Health News:Underwriters Laboratories' Management System Registration Business to Merge With Germany's DQS 2Health News:Agendia Appoints Oncologist Richard A. Bender as Vice President and Chief Medical Officer 2Health News:Agendia Appoints Oncologist Richard A. Bender as Vice President and Chief Medical Officer 3
...
...
...
Tip is bent towards port for downward irrigation. 25G x 5/8in (.50 x 22mm)...
Medicine Products: